These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10974636)

  • 1. Mechanism of the combination effect of wild-type TP53 gene transfection and cisplatin treatment for ovarian cancer xenografts.
    Shimada M; Kigawa J; Kanamori Y; Itamochi H; Takahashi M; Kamazawa S; Sato S; Terakawa N
    Eur J Cancer; 2000 Sep; 36(14):1869-75. PubMed ID: 10974636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to paclitaxel is not related to p53-dependent apoptosis in ovarian cancer cells.
    Takahashi M; Kigawa J; Minagawa Y; Itamochi H; Shimada M; Kamazawa S; Sato S; Akeshima R; Terakawa N
    Eur J Cancer; 2000 Sep; 36(14):1863-8. PubMed ID: 10974635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination effect of adenovirus-mediated pro-apoptotic bax gene transfer with cisplatin or paclitaxel treatment in ovarian cancer cell lines.
    Tsuruta Y; Mandai M; Konishi I; Kuroda H; Kusakari T; Yura Y; Hamid AA; Tamura I; Kariya M; Fujii S
    Eur J Cancer; 2001 Mar; 37(4):531-41. PubMed ID: 11267864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.
    Kigawa J; Sato S; Shimada M; Kanamori Y; Itamochi H; Terakawa N
    Gynecol Oncol; 2002 Feb; 84(2):210-5. PubMed ID: 11812076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL
    Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity and p53-dependent apoptosis in ovarian cancer cells.
    Akeshima R; Kigawa J; Takahashi M; Oishi T; Kanamori Y; Itamochi H; Shimada M; Kamazawa S; Sato S; Terakawa N
    Br J Cancer; 2001 Jun; 84(11):1551-5. PubMed ID: 11384107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells.
    Kanamori Y; Kigawa J; Minagawa Y; Irie T; Oishi T; Shimada M; Takahashi M; Nakamura T; Sato K; Terakawa N
    Eur J Cancer; 1998 Oct; 34(11):1802-6. PubMed ID: 9893672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K; Li Z; Seth P; Cowan KH; Sinha BK
    Oncol Res; 1997; 9(11-12):603-9. PubMed ID: 9563008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type p53 gene transfection in human cultured sarcomas: effect of CDDP.
    Endo K; Kuratate I; Watanabe M; Yoshida H; Teshima R; Osaki M; Ito H
    Oncol Rep; 2001; 8(3):637-42. PubMed ID: 11295094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene status and chemosensitivity in ovarian cancer.
    Kigawa J; Sato S; Shimada M; Takahashi M; Itamochi H; Kanamori Y; Terakawa N
    Hum Cell; 2001 Sep; 14(3):165-71. PubMed ID: 11774736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of cisplatin improves efficacy of 131I-labeled monoclonal antibody 323/A3 in experimental human ovarian cancer.
    Kievit E; Pinedo HM; Schlüper HM; Boven E
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):419-28. PubMed ID: 9226331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Thymoquinone on Apoptosis of SK-OV-3 Ovarian Cancer Cell by Regulation of Bcl-2 and Bax.
    Liu X; Dong J; Cai W; Pan Y; Li R; Li B
    Int J Gynecol Cancer; 2017 Oct; 27(8):1596-1601. PubMed ID: 28692636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo.
    Rogers PM; Beale PJ; Al-Moundhri M; Boxall F; Patterson L; Valenti M; Raynaud F; Hobbs S; Johnston S; Kelland LR
    Int J Cancer; 2002 Feb; 97(6):858-63. PubMed ID: 11857368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts.
    Song K; Cowan KH; Sinha BK
    Oncol Res; 1999; 11(3):153-9. PubMed ID: 10527075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Calycosin-7-O-β-D-Glucoside and its Synergistic Augmentation of Cisplatin-induced Apoptosis in SK-OV-3 Cells.
    Huang JZ; Li LL; Tan XY; Wu ZY; Chen DW; Luo X
    Curr Pharm Des; 2022; 28(26):2161-2166. PubMed ID: 35702792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II)independent of p53 status.
    Husain A; Yan XJ; Rosales N; Aghajanian C; Schwartz GK; Spriggs DR
    Clin Cancer Res; 1997 Nov; 3(11):2089-97. PubMed ID: 9815601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of antitumour activity of cisplatin by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine. HCl in human ovarian cancer cells with intrinsic or acquired resistance to cisplatin.
    Kudoh K; Kikuchi Y; Hiramatsu H; Hirata J; Yamamoto K; Kita T; Nagata I
    Eur J Cancer; 1997 Jan; 33(1):122-8. PubMed ID: 9071911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
    Arafat WO; Gómez-Navarro J; Xiang J; Barnes MN; Mahasreshti P; Alvarez RD; Siegal GP; Badib AO; Buchsbaum D; Curiel DT; Stackhouse MA
    Mol Ther; 2000 Jun; 1(6):545-54. PubMed ID: 10933979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.